PPARGC1A and diabetes mellitus: In the present study, expression of PPAR-α, -β/δ, -γ, and PGC-1α after combination therapy, may imply an amelioration of insulin resistance and improvement of mitochondrial function in skeletal muscle of obesity and diabetes.